The initial drug treatment of older patients with Parkinson's disease - consider an agonist, but don't demonise dopa.
Douglas G
DG
MacMahon
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D052160:Benzothiazoles; D002394:Catechol O-Methyltransferase; D018491:Dopamine Agonists / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D007980:Levodopa / Q000627:therapeutic use*; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D010479:Pergolide / Q000627:therapeutic use; D000077487:Pramipexole; D013844:Thiazoles / Q000627:therapeutic use
D000978:Antiparkinson Agents; D052160:Benzothiazoles; D018491:Dopamine Agonists; D007211:Indoles; D013844:Thiazoles; C046649:ropinirole; D010479:Pergolide; D007980:Levodopa; D000077487:Pramipexole; D002394:Catechol O-Methyltransferase